• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培美曲塞与卡铂联合化疗治疗恶性胸膜间皮瘤并发急性下肢缺血

Acute lower limb ischemia complicating pemetrexed and carboplatin combination chemotherapy for malignant pleural mesothelioma.

作者信息

Valerio Serena, Bracale Umberto Marcello, Giribono Anna Maria, Viviani Emanuela, Caioni Federica, del Guercio Luca

出版信息

Ann Ital Chir. 2014 Nov 3;85(ePub):S2239253X14023019.

PMID:25586574
Abstract

Pemetrexed and Carboplatin are two well-known chemioterapic agents used for the treatment of many tumors, especially for lung cancer and mesothelioma. Peripheral ischemic events related to Pemetrexed and Carboplatin are rarely reported. We herein report a case of lower limb acute ischemia related to combined treatment of Pemetrexed and Carboplatin. A 68-year-old woman was given the chemiotherapic treatment with combination of Pemetrexed and Carboplatin after pleural resection for a malignant pleural mesothelioma. Immediately after the second cycle of treatment, the patient experienced sudden acute left lower limb ischemia. Symptoms resolved after an intra-operative thrombolytic and spasmolytic therapy.

摘要

培美曲塞和顺铂是两种用于治疗多种肿瘤,尤其是肺癌和间皮瘤的著名化疗药物。与培美曲塞和顺铂相关的外周缺血事件鲜有报道。我们在此报告一例与培美曲塞和顺铂联合治疗相关的下肢急性缺血病例。一名68岁女性在因恶性胸膜间皮瘤行胸膜切除术后接受了培美曲塞和顺铂联合化疗。在第二个疗程治疗后不久,患者突然出现急性左下肢缺血。经术中溶栓和解痉治疗后症状缓解。

相似文献

1
Acute lower limb ischemia complicating pemetrexed and carboplatin combination chemotherapy for malignant pleural mesothelioma.培美曲塞与卡铂联合化疗治疗恶性胸膜间皮瘤并发急性下肢缺血
Ann Ital Chir. 2014 Nov 3;85(ePub):S2239253X14023019.
2
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.度伐利尤单抗联合一线化疗用于未经治疗的恶性胸膜间皮瘤(DREAM):一项多中心、单臂、Ⅱ期、有安全爬坡阶段的研究
Lancet Oncol. 2020 Sep;21(9):1213-1223. doi: 10.1016/S1470-2045(20)30462-9.
3
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial.肿瘤电场治疗联合培美曲塞和顺铂或卡铂作为不可切除恶性胸膜间皮瘤的一线治疗(STELLAR):一项多中心、单臂、Ⅱ期临床试验。
Lancet Oncol. 2019 Dec;20(12):1702-1709. doi: 10.1016/S1470-2045(19)30532-7. Epub 2019 Oct 15.
4
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma.铂类培美曲塞和铂类吉西他滨治疗恶性胸膜间皮瘤患者的有效性和安全性。
BMC Cancer. 2015 Jul 9;15:510. doi: 10.1186/s12885-015-1519-z.
5
Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?卡铂和培美曲塞用于治疗恶性胸膜间皮瘤:一种切实可行的治疗选择?
Lung Cancer. 2009 May;64(2):207-10. doi: 10.1016/j.lungcan.2008.08.016. Epub 2008 Oct 15.
6
Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma.培美曲塞与卡铂用于恶性胸膜间皮瘤患者的Ⅰ期临床及药代动力学研究。
J Clin Oncol. 2002 Aug 15;20(16):3533-44. doi: 10.1200/JCO.2002.10.073.
7
[Case of pemetrexed-induced acute lung injury].培美曲塞诱导的急性肺损伤病例
Nihon Kokyuki Gakkai Zasshi. 2009 May;47(5):415-20.
8
Malignant mesothelioma, hypoalbuminaemia and the effect of carboplatin/pemetrexed on survival.恶性间皮瘤、低白蛋白血症和卡铂/培美曲塞对生存的影响。
Clin Oncol (R Coll Radiol). 2013 Dec;25(12):713-8. doi: 10.1016/j.clon.2013.08.009. Epub 2013 Sep 17.
9
A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed.
J Thorac Oncol. 2010 Mar;5(3):405-6. doi: 10.1097/JTO.0b013e3181c8cb16.
10
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.贝伐珠单抗治疗新诊断的胸膜间皮瘤的 Mesothelioma Avastin Cisplatin Pemetrexed 研究(MAPS):一项随机、对照、开放标签、3 期临床试验。
Lancet. 2016 Apr 2;387(10026):1405-1414. doi: 10.1016/S0140-6736(15)01238-6. Epub 2015 Dec 21.